← Back to headlines
Cathie Wood Buys Dip in CRISPR Therapeutics
Investor Cathie Wood has reportedly bought the dip in gene-editing firm CRISPR Therapeutics, indicating confidence in the company's future despite recent market movements.
11 Mar, 10:00 — 11 Mar, 10:00
Sources
Showing 1 of 1 sources
